Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | F-1/A | tm2427973-5_f1a.htm | F-1/A | 2134845 |
| 2 | EXHIBIT 1.1 | tm2427973d6_ex1-1.htm | EX-1.1 | 80940 |
| 3 | EXHIBIT 4.7 | tm2427973d6_ex4-7.htm | EX-4.7 | 94991 |
| 4 | EXHIBIT 4.8 | tm2427973d6_ex4-8.htm | EX-4.8 | 98903 |
| 5 | EXHIBIT 5.1 | tm2427973d6_ex5-1.htm | EX-5.1 | 49722 |
| 6 | EXHIBIT 10.18 | tm2427973d6_ex10-18.htm | EX-10.18 | 206851 |
| 7 | EXHIBIT 23.1 | tm2427973d6_ex23-1.htm | EX-23.1 | 2837 |
| 8 | EX-FILING FEES | tm2427973d6_ex-filingfees.htm | EX-FILING FEES | 31190 |
| 9 | GRAPHIC | lg_evaxion-bwlr.jpg | GRAPHIC | 12591 |
| 10 | GRAPHIC | fc_immun-4c.jpg | GRAPHIC | 105452 |
| 11 | GRAPHIC | fc_strategy-4c.jpg | GRAPHIC | 132876 |
| 12 | GRAPHIC | tb_milestones-4c.jpg | GRAPHIC | 111477 |
| 13 | GRAPHIC | fc_aiimmunology-4c.jpg | GRAPHIC | 91703 |
| 14 | GRAPHIC | fc_cancer-4c.jpg | GRAPHIC | 60354 |
| 15 | GRAPHIC | fc_stageofdevelop-4c.jpg | GRAPHIC | 92932 |
| 16 | GRAPHIC | fc_cells-4c.jpg | GRAPHIC | 51252 |
| 17 | GRAPHIC | bc_bestranked-4c.jpg | GRAPHIC | 36851 |
| 18 | GRAPHIC | lc_cellinoculation-4c.jpg | GRAPHIC | 92243 |
| 19 | GRAPHIC | fc_pioneerrna-4c.jpg | GRAPHIC | 52253 |
| 20 | GRAPHIC | fc_cancervaccines-4c.jpg | GRAPHIC | 42428 |
| 21 | GRAPHIC | fc_vaccinetreat-4clr.jpg | GRAPHIC | 96229 |
| 22 | GRAPHIC | tb_diseasestage-4c.jpg | GRAPHIC | 110882 |
| 23 | GRAPHIC | bc_changetrg-4c.jpg | GRAPHIC | 51187 |
| 24 | GRAPHIC | lc_prepost-bw.jpg | GRAPHIC | 59818 |
| 25 | GRAPHIC | lc_prepostfollow-bw.jpg | GRAPHIC | 46903 |
| 26 | GRAPHIC | lc_pioneerscore-bw.jpg | GRAPHIC | 45148 |
| 27 | GRAPHIC | lc_shortlong-4c.jpg | GRAPHIC | 75791 |
| 28 | GRAPHIC | fc_screening-4c.jpg | GRAPHIC | 25983 |
| 29 | GRAPHIC | bc_sfupbmc-4c.jpg | GRAPHIC | 83884 |
| 30 | GRAPHIC | fc_cd4cd8cells-4c.jpg | GRAPHIC | 74826 |
| 31 | GRAPHIC | lc_neoagspearson-4c.jpg | GRAPHIC | 70888 |
| 32 | GRAPHIC | bc_patient-4c.jpg | GRAPHIC | 67682 |
| 33 | GRAPHIC | bc_preexisting-4c.jpg | GRAPHIC | 81117 |
| 34 | GRAPHIC | fc_evx02-4clr.jpg | GRAPHIC | 95190 |
| 35 | GRAPHIC | lc_empty-4c.jpg | GRAPHIC | 35955 |
| 36 | GRAPHIC | lc_tumar-4c.jpg | GRAPHIC | 59489 |
| 37 | GRAPHIC | lc_tumarvalume-4c.jpg | GRAPHIC | 78429 |
| 38 | GRAPHIC | lc_emptyplasmid-4c.jpg | GRAPHIC | 73045 |
| 39 | GRAPHIC | lc_tumorvolume-4c.jpg | GRAPHIC | 128548 |
| 40 | GRAPHIC | fc_vehiclecontrol-4c.jpg | GRAPHIC | 135671 |
| 41 | GRAPHIC | lc_clinical-4c.jpg | GRAPHIC | 106643 |
| 42 | GRAPHIC | lc_liuhugoanti-4c.jpg | GRAPHIC | 155237 |
| 43 | GRAPHIC | fc_datacuration-4c.jpg | GRAPHIC | 55331 |
| 44 | GRAPHIC | fc_discovery-4c.jpg | GRAPHIC | 160498 |
| 45 | GRAPHIC | lc_bacteria-4c.jpg | GRAPHIC | 154890 |
| 46 | GRAPHIC | fc_proteins-4c.jpg | GRAPHIC | 118887 |
| 47 | GRAPHIC | fc_evxb1-4c.jpg | GRAPHIC | 62087 |
| 48 | GRAPHIC | lc_postinfection-4c.jpg | GRAPHIC | 22562 |
| 49 | GRAPHIC | lc_abcessarea-4c.jpg | GRAPHIC | 37776 |
| 50 | GRAPHIC | lc_halfmaxtiter-4c.jpg | GRAPHIC | 21103 |
| 51 | GRAPHIC | lc_kidneys-4c.jpg | GRAPHIC | 24535 |
| 52 | GRAPHIC | fc_ngo265-4c.jpg | GRAPHIC | 174298 |
| 53 | GRAPHIC | lc_postinfections-4c.jpg | GRAPHIC | 277722 |
| 54 | GRAPHIC | lc_auccfu-4c.jpg | GRAPHIC | 62059 |
| 55 | GRAPHIC | lc_immunizations-4c.jpg | GRAPHIC | 25560 |
| 56 | GRAPHIC | bc_splenocytes-4c.jpg | GRAPHIC | 38054 |
| 57 | GRAPHIC | bc_killing-4c.jpg | GRAPHIC | 65238 |
| 58 | GRAPHIC | fc_identification-4c.jpg | GRAPHIC | 82717 |
| 59 | GRAPHIC | bc_sarsgenome-4c.jpg | GRAPHIC | 38363 |
| 60 | GRAPHIC | bc_antibody-4c.jpg | GRAPHIC | 20090 |
| 61 | GRAPHIC | tm2427973d4_ex5-1img001.jpg | GRAPHIC | 3052 |
| 62 | GRAPHIC | tm2427973d4_ex5-1img02.jpg | GRAPHIC | 763 |
| Complete submission text file | 0001104659-24-129424.txt | 8181094 |
EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-283304 | Film No.: 241556626
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)
